熱門資訊> 正文
Vaccinex行使620万美元收益授权
2024-09-18 20:46
- Vaccinex (NASDAQ:VCNX) said on Wednesday it has entered into definitive agreements for the immediate exercise of outstanding warrants to purchase 1.07M shares of common stock at the reduced exercise price of $5.636 per share.
- The gross proceeds from the exercise of the existing warrants together with the sale of the new warrants is expected to be approximately $6.2 million.
- Vaccinex (VCNX) shares were down 2% in Wednesday premarket trading.
More on Vaccinex
- Vaccinex says Alzheimer's candidate buoyed by additional early-stage data
- Vaccinex stock plunges 24% on mixed results for Alzheimer's study
- Financial information for Vaccinex
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
